Novel application of exosome of mesenchymal stem cell source
A technology of mesenchymal stem cells and exosomes, applied in the field of exosomes derived from mesenchymal stem cells, to achieve the effects of delaying disease progression, lasting therapeutic effect, and easy circulation
Active Publication Date: 2016-06-29
沈慧勇
View PDF4 Cites 20 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0008] But so far, there are no reports and patents on the
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0032] Exosomes derived from MSCs for the treatment of chronic inflammation and pathological osteogenesis in AS
[0033] (1) Volunteer screening
[0034] Volunteers aged 20 to 30 were selected to undergo a physical examination according to the required items. After passing the test, an appointment was made to extract 30ml of bone marrow.
[0035] (2) Isolation and identification of MSCs
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention discloses application of an exosome of a mesenchymal stem cell source in preparation of a drug for treating ankylosing spondylitis. The exosome of the mesenchymal stem cell source has the inhibition effect on both chronic inflammations and pathological osteogenesis and has the advantages of being low in side effect and cost and more durable in effect.
Description
technical field [0001] The present invention relates to the use of exosomes derived from mesenchymal stem cells, in particular to the application of exosomes derived from mesenchymal stem cells in the preparation of drugs for treating ankylosing spondylitis. Background technique [0002] Ankylosing spondylitis (abbreviated as AS) is a common autoimmune disease with a high prevalence rate of about 0.2-0.54% in my country (see: RongJ, JieruoG.SpondyloarthritisinChina.Currentopinioninrheumatology.2013; 25(4 ):460-7.). AS tends to occur in young males and often involves axial bone joints. The main clinical and pathological features are chronic progressive inflammation and pathological osteogenesis (see: BraunJ, SieperJ. Ankylosingspondylitis. Lancet. 2007; 369(9570): 1379- 90.). However, the pathogenesis of AS is still unclear, and the relationship between its two major pathological features-inflammation and osteogenesis is also unclear. The unclear pathogenesis leads to the li...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more IPC IPC(8): A61K35/28A61P19/00A61P29/00C12N5/0775
Inventor 沈慧勇王鹏吴燕峰伍小华高梁斌黄霖唐勇陈铿谢中瑜
Owner 沈慧勇
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap